Literature DB >> 15338480

Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra).

Carl Turesson, Kristian Riesbeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15338480

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Successful treatment of refractory adult onset Still's disease with rituximab.

Authors:  K Ahmadi-Simab; P Lamprecht; C Jankowiak; W L Gross
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

Review 2.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19

Review 3.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

4.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06

5.  Essential role of interleukin-1 signaling in host defenses against group B streptococcus.

Authors:  Carmelo Biondo; Giuseppe Mancuso; Angelina Midiri; Giacomo Signorino; Maria Domina; Veronica Lanza Cariccio; Mario Venza; Isabella Venza; Giuseppe Teti; Concetta Beninati
Journal:  mBio       Date:  2014-09-09       Impact factor: 7.867
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.